Who we are?
◍ Vertically integrated producer of high margin cannabis extracts and non-smokeable products for recreational, health & wellness and medicinal use
◍ International presence in the USA, Latam and Western Europe
◍ Global supply chain with low cost sourcing from Colombia
◍ Led by a team combining 50+ years of cannabis industry experience, regulatory know how and executive leadership of multinational public companies.
◍ Founded in 2016 and CF positive 12 months post launch
◍ All funding to date provided by founders, now raising a 10M USD Series A : 6M USD Colombia + 4M USD USA
Presence in markets with 800M population
Our vision and strategy
Industry
Cultivation commoditizing
Shift to non-smokeable products
Blurring boundaries between medical, recreational and health
Emerging brands
Opening of international markets
Key success factors
Low cost and scale
Product innovation
Customer
orientation
Digital and social media marketing
In-depth local regulatory insight
Folium strategy
Low-cost Colombian cultivation
Oil, concentrates and MIPS focus
Different BUs
per end market
Experienced online marketing team
Local partnerships
Medical division:
Foliumed Bogotá, Colombia
History
We started the application process for cultivation, extraction and export licences for psychoactive and non-psychoactive cannabis (CBD) in Q4 2017. Our decision to locate our medical division in Colombia has been based upon the country’s unique growing conditions, the availability of highly skilled human resources and a favorable, export- oriented regulatory framework.
Growth strategy
Following licence approval in Q3 2018, we will build out our 16 hectare cultivation and GMP extraction site in close proximity to Bogota. Our commercial strategy is to provide affordable, efficacy-proven prescription medicines and innovative OTC products to:
Latin America
a market with
625 M people
where high cost LPs won’t be able to compete.
Major regulated import
markets such as
Germany or Canada
where demand outstrips supply
Facts and figures
Total cultivation capacity:
77 tons
of dried flower per annum
Total oil extraction capacity:
12 tons
of oil per annum
Adult use:
Strategic partnership with TapRoot Las Vegas, USA
TapRoot is a Las Vegas-based producer of premium cannabis oils for leading brands
• Since start of operations in July 2017, we produced over 200,000 grams of cannabis extracts
• Primary focus on extraction – currently limited cultivation and propagation of proprietary genetics
• Exceptional quality: Our average THC content of 92%is well above industry average of 70%
We are expanding our currently limited footprint from 1,000 to 17,000 square feet
• Develop a 8,500 square foot cultivation space for cannabinoid specific health & wellness related products
•Increase oil production capacity to 2000 kg/p.a
• Enable production of branded flower, edibles and concentrates multiplying our accessible market by 10x
• Prepare facility for cGMP certification
We also are applying for additional licenses in Las Vegas
Participating in licensing process with applications for 8 Nevada dispensaries submitted
Facts and figures
Oil production capacity post 2018 expansion:
2000 kg/p.a.
BtoB market share:
15%
BtoB market share:
5%
Distribution reach:
25% of Nevada PoS
Our Products
Medical Products
Adult Use Products
Founder Team
Oliver Zugel
Co-founder and Chairman
-
- Former CEO of multinational gaming companies in Europe and Latam
- Increased EBITDA from 70 to 300 M Euros and prepared IPO for a 2 bn USD company
- Background in strategy consulting and PE with Michael Porter’s Monitor Company
- 1st Class Degree from the LSE
Shane Terry
CEO Taproot Nevada
- Co-founder of Taproot and CEO of several US cannabis companies
- Former President of Nevada Dispensary Association and Board Member of cannabis company GB Sciences
- #1 Flight Commander in the US Air Force for over 130,000 personnel
Diego Felipe Navarro
Co-founder, CEO Colombia
- Co-founder of FoliuMed Colombia
- Former CEO of Codere Colombia & Panamá, the no. 2 gaming operator with 1,500 employees.
- Industrial Engineering honors graduate of the Javeriana University in Bogotá, EMBA from Los Andes University in Bogotá. IE Business School.
News
High Yield Insights CBD Consumer Experience, London, August 2019. FoliuMed CBD products.
The CBD Consumer Experience: Part Two draws from a national representative online (mobile and desktop) survey of U.S. adults aged 21+. The survey was fielded January 14-23, 2019 among 2,000 […]
Colombian Producer FoliuMed Launches CBD Sales in Europe
Colombian medical cannabis producer FoliuMed has successfully launched its line of products at CBD Europe, a leading European trade show. FoliuMed’s offering includes bulk cannabis extracts as well as branded […]
MJBiz – Big changes in store for Colombia cannabis regulations, but final rules and timeline uncertain
A draft decree in Colombia is in the works that could substantially modify certain aspects of the current medical cannabis framework.
Health Europa – The changing attitudes of the cannabis industry and shift towards non-smokeable products
Oliver Zugel, CEO of Foliumed, talks to us about the market dynamics of the Columbian cannabis industry, his company’s strategy and the emerging shift towards non-smokeable products.